118 related articles for article (PubMed ID: 381324)
21. Dynamics of basal pituitary gonadotropin secretion and responsiveness to LRH following estradiol benzoate in normal girls.
Gurewitz R; Dickerman Z; Peleg S; Keret R; Gidali A; Laron Z
Horm Res; 1982; 16(3):174-81. PubMed ID: 6809554
[TBL] [Abstract][Full Text] [Related]
22. [Increased and prolonged release of lh and fsh on intravenous administration of a synthetic analogue of lh-rh [d-ser(tbu)6-ea10-lh-rh] in healthy men of various age groups (author's transl)].
Vierhapper H; Waldhäusl W
Wien Klin Wochenschr; 1980 Jun; 92(13):461-3. PubMed ID: 6775419
[TBL] [Abstract][Full Text] [Related]
23. Prolonged pulsatile administration of luteinizing hormone-releasing hormone in prepubertal children: diagnostic and physiologic aspects.
Delemarre-van de Waal HA; Van den Brande JL; Schoemaker J
J Clin Endocrinol Metab; 1985 Nov; 61(5):859-67. PubMed ID: 3930552
[TBL] [Abstract][Full Text] [Related]
24. Effect of clomiphene on basal and LRH-induced gonadotropin secretion in postmenopausal women.
Hashimoto T; Miyai K; Izumi K; Kumahara Y
J Clin Endocrinol Metab; 1976 Mar; 42(3):593-4. PubMed ID: 767356
[TBL] [Abstract][Full Text] [Related]
25. [Effects of a new analogue of LH-RH, D-Ser(TBU)6- EA10-LH-RH, on gonadotropin liberation in males (author's transl)].
Kuhl H; Kaplan HG; Taubert HD
Dtsch Med Wochenschr; 1976 Mar; 101(10):361-4. PubMed ID: 129323
[TBL] [Abstract][Full Text] [Related]
26. Differing responses of plasma bioactive and immunoreactive follicle-stimulating hormone and luteinizing hormone to gonadotropin-releasing hormone antagonist and agonist treatments in postmenopausal women.
Matikainen T; Ding YQ; Vergara M; Huhtaniemi I; Couzinet B; Schaison G
J Clin Endocrinol Metab; 1992 Sep; 75(3):820-5. PubMed ID: 1517372
[TBL] [Abstract][Full Text] [Related]
27. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.
de Ziegler D; Steingold K; Cedars M; Lu JK; Meldrum DR; Judd HL; Chang RJ
J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501
[TBL] [Abstract][Full Text] [Related]
28. Suppressive effect of an inhibitory LHRH analog on the gonadotropin response to LHRH in normal women.
Canales ES; Montvelinsky H; Zárate A; Kastin AJ; Coy DH; Schally AV
Int J Fertil; 1980; 25(3):190-2. PubMed ID: 6108928
[TBL] [Abstract][Full Text] [Related]
29. The luteinizing hormone-releasing hormone (LHRH) agonist [D-Trp6-Pro9-NEt]LHRH increased rather than lowered LH and alpha-subunit levels in a patient with an LH-secreting pituitary tumor.
Roman SH; Goldstein M; Kourides IA; Comite F; Bardin CW; Krieger DT
J Clin Endocrinol Metab; 1984 Feb; 58(2):313-9. PubMed ID: 6198331
[TBL] [Abstract][Full Text] [Related]
30. The biologic activity of a potent analogue of gonadotropin-releasing hormone in normal and hypogonadotropic men.
Crowley WF; Beitins IZ; Vale W; Kliman B; Rivier J; Rivier C; McArthur JW
N Engl J Med; 1980 May; 302(19):1052-7. PubMed ID: 6767977
[TBL] [Abstract][Full Text] [Related]
31. Reproductive hormones in aging men. II. Basal pituitary gonadotropins and gonadotropin responses to luteinizing hormone-releasing hormone.
Harman SM; Tsitouras PD; Costa PT; Blackman MR
J Clin Endocrinol Metab; 1982 Mar; 54(3):547-51. PubMed ID: 6799540
[TBL] [Abstract][Full Text] [Related]
32. Intermittent long-term administration of a potent gonadotropin-releasing hormone agonist in normal men.
Doelle G; Linde R; Alexander N; Kirchner F; Vale W; Rivier J; Rabin D
Int J Fertil; 1982; 27(4):234-7. PubMed ID: 6131043
[TBL] [Abstract][Full Text] [Related]
33. Acute inhibitory effects of 17 beta-estradiol are observed on gonadotropin secretion from perifused pituitary fragments of metestrous, but not proestrous, rats.
Fallest PC; Schwartz NB
Endocrinology; 1991 Jan; 128(1):273-9. PubMed ID: 1898881
[TBL] [Abstract][Full Text] [Related]
34. The role of estrogen in the modulation of pituitary sensitivity of LRF (luteinizing hormone-releasing factor) in men.
Wang CF; Lasley BL; Yen SS
J Clin Endocrinol Metab; 1975 Jul; 41(1):41-3. PubMed ID: 1097463
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
Rebar R; Judd HL; Yen SS; Rakoff J; Vandenberg G; Naftolin F
J Clin Invest; 1976 May; 57(5):1320-9. PubMed ID: 770505
[TBL] [Abstract][Full Text] [Related]
36. Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in the human male. III. Effects of long term combined treatment with GnRH agonist and androgen.
Bhasin S; Heber D; Steiner BS; Handelsman DJ; Swerdloff RS
J Clin Endocrinol Metab; 1985 May; 60(5):998-1003. PubMed ID: 3920237
[TBL] [Abstract][Full Text] [Related]
37. Gonadotropin and alpha-subunit responses to chronic gonadotropin-releasing hormone analog administration in patients with glycoprotein hormone-secreting pituitary tumors.
Klibanski A; Jameson JL; Biller BM; Crowley WF; Zervas NT; Rivier J; Vale WW; Bikkal H
J Clin Endocrinol Metab; 1989 Jan; 68(1):81-6. PubMed ID: 2535852
[TBL] [Abstract][Full Text] [Related]
38. The effect of D-Trp6-LRH upon secretion of gonadotrophin--a possible therapeutic application in anorexia nervosa.
Zgliczyński S; Baranowska B; Jeske W; Niewiadomska A; Rozbicka G; Schally AV
Acta Endocrinol (Copenh); 1984 Feb; 105(2):161-6. PubMed ID: 6229967
[TBL] [Abstract][Full Text] [Related]
39. Failure of positive feedback of oestradiol during chronic intranasal luteinizing hormone-releasing hormone agonist treatment.
Bergquist C; Nillius SJ; Wide L
Clin Endocrinol (Oxf); 1982 Feb; 16(2):147-51. PubMed ID: 6802530
[TBL] [Abstract][Full Text] [Related]
40. Luteolysis induced by a luteinizing hormone-releasing hormone agonist is prevented by human chorionic gonadotropin.
Bergquist C; Nillius SJ; Wide L
Contraception; 1980 Oct; 22(4):341-7. PubMed ID: 7004772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
